<DOC>
	<DOC>NCT00528697</DOC>
	<brief_summary>The purpose of this study is to test if the investigational medication ABT-089 is a safe and effective treatment for children with Attention-Deficit/Hyperactivity Disorder or ADHD.</brief_summary>
	<brief_title>A Safety and Efficacy Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Attention Deficit Disorder with Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Atomoxetine Hydrochloride</mesh_term>
	<criteria>Have voluntarily signed an informed consent form Meet diagnostic criteria for attentiondeficit/hyperactivity disorder (ADHD) based on detailed evaluation and interview with parent(s) First grade or higher in a school setting 3 days/week Subject is generally in good health based on medical history, physical examination, clinical lab tests, and ECG Subject weighs at least 37 pounds (17 kg) Female subjects of childbearing potential must have a negative urine pregnancy test at screening and baseline and agree to comply with applicable contraceptive requirements Subject and parents have been judged by the study doctor to be reliable to keep required appointments for clinic visits and all tests, including blood draws, and examinations Subject is not functioning at an ageappropriate level intellectually Subject has a current or past diagnosis of bipolar disorder, psychosis, autism, Asperger's syndrome, or pervasive developmental disorder Current diagnosis of obsessivecompulsive disorder, eating disorder, anxiety disorder or depressive disorder requiring treatment of any kind Subject has a history of significant allergic reaction to any drug Subject requires ongoing treatment with any psychiatric medication Subject has a serious medical condition, seizure disorder (except febrile seizures as an infant), or history of substance abuse or dependence</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>